8 Mar 16

There is also, before the next season allergic rhinitis. Learn is a leading global specialty pharmaceutical company. The company specializes in marketing and pharmaceutical development in late clinical stage. Acquisitions and long – term partnerships are fundamental factors the company’s strategy the company’s strategy. By its own organizations by its own organizations in 40 countries. Meda in 120 countries worldwide in 120 countries worldwide. The Meda share is listed under Large Cap on the OMX Nordic Stock Exchange.

Researchers at the University Medical Center Utrecht, the Netherlands, describe these findings, which are published online on September 12 is in the journal Cancer Cell.These two patients be member of a new study from Northwestern University Feinberg School of Medicine RADAR project which by Charles Bennett, performed that Left rituximab on PML. Rituximab is the most important and commonly used cancer drug of lymphoma. It be also rheumatoid arthritis and of rheumatoid arthritis and is frequent off-label in multiple sclerosis Discoid Lupus Erythematosus lupus erythematosus and autoimmune anemia.

One of two others drug, other drug hit by the market last April, since the PML risk. To other drug, Tysabri was removed from the market for 1? Year due similar concerns.